Advanced Search
QI Xiaowei, JIN Linfang, PU Yong, FENG Jingjie, LIU Yankui, HUA Dong. Expression of CXCR5, CXCL13, MMP-12 and MMP-13 in Colorectal Cancer and Their Significance[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 159-163. DOI: 10.3971/j.issn.1000-8578.2015.02.013
Citation: QI Xiaowei, JIN Linfang, PU Yong, FENG Jingjie, LIU Yankui, HUA Dong. Expression of CXCR5, CXCL13, MMP-12 and MMP-13 in Colorectal Cancer and Their Significance[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 159-163. DOI: 10.3971/j.issn.1000-8578.2015.02.013

Expression of CXCR5, CXCL13, MMP-12 and MMP-13 in Colorectal Cancer and Their Significance

More Information
  • Received Date: October 07, 2013
  • Revised Date: August 06, 2014
  • Objective To investigate the expression of CXCR5, CXCL13, MMP-12 and MMP-13, and to explore their relationship with clinicopathologic features and prognosis of colorectal carcinoma. Methods The immunohistochemistry staining method was used to detect the expression of CXCR5, CXCL13, MMP-12 and MMP-13 protein in 236 paired specimens of colorectal cancer and normal tissues and 62 cases of colorectal adenoma. Results The positive rates of CXCR5, CXCL13, MMP-12 and MMP-13 were 43.6%, 41.5%, 83.5% and 80.5% in colorectal carcinoma tissues, respectively, which were much higher than those in incisal edge normal intestinal mucosa tissues (4.2%, 5.5%, 11.9% and 13.1%) and those in colorectal adenomas tissues(24.2%, 17.7%, 69.4% and 64.5%) (P<0.05). The expression of CXCR5, CXCL13, MMP-12 and MMP-13 were positively correlated with lymph node metastasis, distant metastasis, TNM stage and relapse(P<0.05). Additionally, CXCL13 positive staining was correlated with poor differentiation(P<0.05). CXCR5 expression was significantly correlated with CXCL13 expression(P<0.05). The expression of CXCR5 and CXCL13 were positively correlated with MMP-12 and MMP-13, respectively (P<0.05). Conclusion The expression of CXCR5,CXCL13,MMP-12 and MMP-13 may play a crucial role in the carcinogenesis, development, metastasis and relapse of colorectal cancer. They could be used as prognostic markers of colorectal cancer in clinical practice.
  • [1]
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
    [2]
    Markowitz SD, Dawson DM, Willis J, et al. Focus on colon cancer[J]. Cancer Cell, 2002, 1(3): 233-6.
    [3]
    Labianca R, Nordlinger B, Beretta GD, et al. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up[J]. Ann Oncol, 2010, 21 Suppl 5: v70-7.
    [4]
    Franciszkiewicz K, Boissonnas A, Boutet M, et al. Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response[J]. Cancer Res, 2012, 72 (24): 6325-32.
    [5]
    Kataoka H, Tanaka H, Nagaike K, et al. Role of cancer cell-stroma interaction in invasive growth of cancer cells[J]. Hum Cell, 2003, 16 (1): 1-14.
    [6]
    Müller G, Höpken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity[J]. Immunol Rev, 2003, 195: 117-35.
    [7]
    Bürkle A, Niedermeier M,Schmitt-Gräff A, et al. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia[J]. Blood, 2007, 110(9): 3316-25.
    [8]
    Meijer J, Zeelenberg IS, Sipos B, et al. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver[J]. Cancer Res, 2006, 66(19): 95 76-82.
    [9]
    Freije JM, Díez-Itza I, Balbín M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas[J]. J Biol Chem,1994, 269(24): 16766-73.
    [10]
    Mori M, Barnard GF, Mimori K, et al. Overpression of matri x metalloproteinase-7 mRNA in human colon carcinomas[J]. Cancer, 1995, 75(6 Suppl): 1516-9.
    [11]
    VAN Nguyen S, Skarstedt M, Löfgren S, et al. Gene polymorphism of matrix metalloproteinase-12 and -13 and association with colorectal cancer in Swedish patients[J]. Anticancer Res, 2013, 33 (8): 3247-50.
    [12]
    Razis E, Kalogeras KT, Kotoula V, et al. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13- CXCR5 messenger RNA expression[J]. Clin Breast Cancer, 2012, 12 (3): 183-93.
    [13]
    Rath T, Stöckle J, Roderfeld M, et al. Matrix metalloproteinase- 13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration[J]. Oncol Lett, 2011, 2(3): 483-8.
  • Related Articles

    [1]CHU Xuelei, AN Chen, XI Lingze, XIE Hongting, ZONG Mingtong, XUE Peng, ZHU Shijie. Predictive Value of Immune Inflammation Combined with Liver Function Hematological Indicators for Metastasis of Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2024, 51(9): 764-771. DOI: 10.3971/j.issn.1000-8578.2024.24.0211
    [2]KONG Xiangxing, LI Jun. Advances and Challenges in Prognosis Prediction Systems for Non-metastatic Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2020, 47(12): 919-924. DOI: 10.3971/j.issn.1000-8578.2020.20.0608
    [3]CHEN Chao, ZHAO Yamei, GE Xiaoxu, WANG Jian, WANG Da, DING Kefeng, SUN Lifeng. Current Status and Challenges of Treatment on Colorectal Cancer Peritoneal Metastasis with Ovarian Metastasis[J]. Cancer Research on Prevention and Treatment, 2020, 47(12): 915-918. DOI: 10.3971/j.issn.1000-8578.2020.20.0581
    [4]WU Xueliang, WANG Likun, XUE Jun, YANG Dongdong, QU Ming, GUO Fei, ZHANG Pengcheng, HAN Lei, LIU Bo. Expression and Correlation Studies of Id-1, MMP-9, and LMVD in Colorectal Adenocarcinoma Tissues[J]. Cancer Research on Prevention and Treatment, 2016, 43(11): 959-963. DOI: 10.3971/j.issn.1000-8578.2016.11.008
    [5]ZHANG Yan, CHEN Qi. Progress of Relationship between Matrix Metalloproteinases and Occurrence and Development of Ovarian Cancer[J]. Cancer Research on Prevention and Treatment, 2015, 42(12): 1257-1261. DOI: 10.3971/j.issn.1000-8578.2015.12.019
    [6]REN Qing, XIONG Ruihua, TIAN Xiurong, BAO Zhongping, TANG Xinyun, LUO Kepin. 125I Seed Implantation Combined with Chemotherapy for Colorectal Cancer with Postoperative Liver Metastasis[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 653-656. DOI: 10.3971/j.issn.1000-8578.2014.06.032
    [7]XU Hua, LIU An-wen, XIE Chun-ying, WU Jian-bing. Clinical Study of TACE with Irinotecan and Lipiodol Combining with Intravenous Chemotherapy of CF/5-Fu in Treatment of Hepatic Metastasis from Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2009, 36(08): 696-698. DOI: 10.3971/j.issn.1000-8578.2009.08.019
    [8]YU Jian-bo, YIN Ping, L I Zhi-qiang, LI Jing, WANG Yu-mei. The Relative Study between Expression of MMP-9 、VEGF and MVD in Human Colorectal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2005, 32(01): 30-32. DOI: 10.3971/j.issn.1000-8578.1401
    [9]ZHNAG Yong-gang. Relative Histopathologic Evaluation of Colorectal Cancer with Liver Metastasis[J]. Cancer Research on Prevention and Treatment, 2004, 31(10): 655-656. DOI: 10.3971/j.issn.1000-8578.2093
    [10]CAO Ge, SHEN Zhi-xiang, HUANG Jie-an, et al. Correlation between expression of CD44v6, MMP-2 and nm23-H1 in colorectal carcinoma and its clinicalopathological characters[J]. Cancer Research on Prevention and Treatment, 2002, 29(01): 53-56. DOI: 10.3971/j.issn.1000-8578.126

Catalog

    Article views (1294) PDF downloads (516) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return